🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honored to receive the Walter J. Pories Research Award — a prestigious national honor presented annually by the TREO Foundation. The award recognizes groundbreaking research & scientific contributions that have significantly advanced the understanding of #obesity 1/2

🚨New ACHIEVE-1 phase 3 data 🚨 Orforglipron in T2DM ⬇️A1c 1.6% reduction ⬇️Weight reduction 7.9% GI adverse events comparable to other GLP1s Discontinuation due to adverse events 5-8% (3-6% due to GI AE) Comparable A1c reduction to oral semaglutide PIONEER-1 trial Newly

New Obesity Standards of Care by ADA are released! ASMBS IFSO The Obesity Society Obesity Medicine Association OAC World Obesity Obesity Care Advocacy Network Pennington Biomedical Research Center Neil Floch MD Jaime Ponce MD Ricardo Cohen Francesco Rubino Dr. John Kirwan Vance L. Albaugh, MD, PhD, DABOM, DABS-FPMBS

The GLP1 discontinuation rate in the real world is alarmingly high. 64% at 1 year and 84% at 2 years in those without diabetes‼️ Risk factors of discontinuation include lower income, older age, lower weight loss, cost, among others. 🔬Further research into the predictors of

P3 CagriSema in adults with overweight #obesity Placebo subtracted #weightloss of 17.3%; 60.2% & 40.4% achieved 20% and 25% weight loss, respectively American Diabetes Association #ADA2025 nejm.org/doi/full/10.10…

Congratulations Michel, well deserved lifetime achievement award ASMBS Treo Foundation

Thank you, Eric Ravussin, for sharing the updated definition of clinical obesity at the 85th Scientific Sessions of the American Diabetes Association meeting. The definition recognizes "clinical obesity" as a persistent condition characterized by distinct diagnostic parameters that surpass

Great ASMBS meeting last week - very proud of our #metabolic #surgery fellows and trainees #Metamor #ASMBS25 The future is bright!

Great work from Dr. Michael Kachmar - Belly Flop Syndrome... and much more! Extremely proud of you Michael Kachmar, DO, DABS, DABOM Pennington Biomedical Research Center and all of us at #Metamor are excited to watch you launch your career!

🚨 GLP-1s vs Surgery: Who Wins Long Term? - - - A new 2-year comparative study from NYU Langone just dropped—and the results are clear: 📊 Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide): 🔹 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat)

Metabolic surgery reduces CRC disease progression through circulating bile acid diversion - very exciting, mechanistic study! #cancer #wls #obesity ⁦ASMBS⁩ ⁦The Obesity Society⁩ ⁦Philip Schauer, MD⁩ ⁦Jerry Dang, MD PhD⁩ ⁦⁦Tom Shin, MD PhD⁩ pubmed.ncbi.nlm.nih.gov/40561000/

“He saved my life.” Living with severe PCOS, she faced weight gain, hormonal imbalance & pain until she met Dr. Aayed. After bariatric surgery: ✅ Pain-free eating ✅ Quick movement ✅ Natural pregnancy Metabolic surgery isn’t just weight loss. It’s a new life. #NewBeginning

Great press on this top paper from my collegues and friends from NYU asmbs.org/resources/glp-… ASMBS IFSO IFSO North America Chapter New York University NYU Langone Surgery

Childhood & adolescent obesity isn’t about willpower, it’s about biology, environment & early intervention. At IFSO, we support multidisciplinary, age-appropriate care to build lifelong healthy habits. Every child deserves a confident, healthy future. 💙 #ObesityAdolescents

Today at Pennington Biomedical Research Center, we celebrated a momentous occasion as Governor Jeff Landry signed Senator Patrick McMath's MAHA bill into law. The presence of HHS Secretary, Robert F. Kennedy, Jr., underscored the importance of this event. Our state-funded Greaux

Retrospective claims data reveals over 20 % of GLP-1 medicine users had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment. pdf.sciencedirectassets.com/780950/1-s2.0-…

Ever wondered how we manage our weight? Join our DIP study to help us find out. We are seeking men and women, ages 18 to 40. You can earn up to $1,500. Meals also provided at no cost to you. Learn more: pbrc.edu/DIP

Compared with monotherapy or non-pharmacologic #WeightLoss, a multimodal #AntiObesityMedication regimen elicited more preoperative weight loss in high BMI patients. Michael Kachmar, DO, DABS, DABOM Kyle LaPenna, MD, PhD Vance L. Albaugh, MD, PhD, DABOM, DABS-FPMBS Philip Schauer, MD Pennington Biomedical Research Center LSU Health Sciences endocrinologyadvisor.com/news/multimoda…

We are proud to be recognized by Secretary Kennedy as the leading institution in the country on nutrition, food, and health.

We at Pennington Biomedical Research Center wish you all a happy and safe #IndependenceDay! Our office is closed today and will reopen for normal business operations on Monday, July 7th. 🎆